Tachycardia-induced Cardiomyopathy — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Tachycardia-induced cardiomyopathy (tachymyopathy) — sustained rapid ventricular rates can cause reversible LV dysfunction which recovers after adequate rate or rhythm control
Tachycardia-induced cardiomyopathy (tachymyopathy) is a reversible cause of LV dysfunction resulting from sustained rapid ventricular rates. It can be caused by any tachyarrhythmia (AF, atrial flutter, incessant SVT, high PVC burden). The mechanism involves chronic metabolic depletion, cellular remodelling, and neurohormonal activation from persistent tachycardia. Key features: (1) LV dysfunction temporally related to tachycardia; (2) recovery of LVEF after adequate rate/rhythm control (typically within 1-6 months); (3) absence of other causes of cardiomyopathy. The 2024 ESC AF Guidelines recognise tachymyopathy as an important reversible cause of HF. It must be distinguished from AF occurring as a consequence of pre-existing cardiomyopathy — in tachymyopathy, the arrhythmia is the cause, not the consequence.
Reference: ESC (2024): AF Guidelines; ESC (2023): HF Guidelines